大阪大学 · 生化学・遺伝学・分子生物学
Satoshi Obika教授の研究室は、合成核酸化学を基盤とし、ナノテクノロジーと医療応用を結びつける先端的研究を展開しています。特に、糖環を架橋することで分子の柔軟性を制御する「ブリッジドヌクレア酸(BNA)」や、アミド結合を導入した新規XNA(キノン核酸)の開発が目立ち、がんや高コレステロール血症の標的治療に応用可能な高安定・高親和性オリゴヌクレオチドを創出しています。また、標的mRNAの特異的ノックダウンを可能にする抗センスオリゴヌクレオチドの開発も進んでいます。
Figures are computed from collected data and may differ slightly.
Xeno nucleic acids (XNAs) are a group of chemically modified nucleic acid analogues that have been applied to various biological technologies such as antisense oligonucleotides, siRNAs and aptamers.
Towards the next generation: New LNA analogues based on a cyclic amide structure, termed amido-bridged nucleic acids (AmNAs), have been synthesized. Oligonucleotides modified with these residues showed high nuclease resistance along with high binding affinities towards complementary strands. Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the aut
Recent findings in molecular biology implicate the involvement of proprotein convertase subtilisin/kexin type 9 (PCSK9) in low-density lipoprotein receptor (LDLR) protein regulation. The cholesterol-lowering potential of anti-PCSK9 antisense oligonucleotides (AONs) modified with bridged nucleic acids (BNA-AONs) including 2',4'-BNA (also called as locked nucleic acid (LNA)) and 2',4'-BNA(NC) chemistries were demonstrated both in vitro and in vivo. An in vitro transfection study revealed that all
Restricting the sugar moiety of a nucleic acid to a single conformation can be accomplished by forming a bridge in the sugar.A large number of bridged nucleic acids with variable bridged structures and conformations have been developed.The synthesis and properties of these artificial nucleic acid analogues are discussed.Such conformational restriction of the sugar moiety significantly improved the properties of the nucleic acid.
Significantly enhanced binding affinity to C⋅G base pairs without loss of sequence selectivity is achieved by using a nucleotide containing a 2-pyridone and a 2'-O,4'-C-methylene-bridged nucleic acid analogue (P<sup>B</sup> , see picture). The degree of stabilization of the triplex formed enables C⋅G interruptions in a homopurine⋅homopyrimidine double-stranded DNA to be detected.
Novel bicyclic nucleoside analogues 3′-O,4′-C-methyleneribonucleosides 1 are conveniently prepared starting from uridine; the sugar puckering of 1 is found to be nearly in the S-conformation by means of PM3 calculations and 1 H NMR studies.
Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) is a reactive oxygen species (ROS) involved in various diseases, including neurodegeneration, diabetes, and cancer. Here, we introduce a new approach to use H<sub>2</sub>O<sub>2</sub> to modulate specific gene expression in mammalian cells. H<sub>2</sub>O<sub>2</sub>-responsive nucleoside analogues, in which the Watson-Crick faces of the nucleobases are caged by arylboronate moieties, were synthesized. One of these analogues, boronated thymidine (<b
A novel 2',4'-BNA/LNA analog bridged by guanidine, termed as guanidine bridged nucleic acid (GuNA), was synthesized and incorporated into oligonucleotides. Thermal stabilities and nuclease resistance of GuNA-modified oligonucleotides were investigated and compared with those of 2',4'-BNA/LNA and natural DNA oligonucleotides. GuNA exhibited interestingly high binding affinity towards complementary ssDNA than 2',4'-BNA/LNA.
High scalability of a novel bicyclic nucleoside building block, amido-bridged nucleic acid (AmNA), to diversify pharmacokinetic properties of therapeutic antisense oligonucleotides is described. N2'-functionalization of AmNA with a variety of hydrophobic groups is straightforward. Combinations of these modules display similar antisense knockdown effects and improve cellular uptake, relative to sequence-matched conventional 2',4'-bridged nucleic acid (2',4'-BNA) in vivo.
Open papers in the app to read, cite, and organize with AI.